Analyst consensus rating
DarioHealth Analyst Rating: none
Direct answer
DarioHealth's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $14.00.
Forecast evidence checked September 12, 2026.
Get free DarioHealth email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.93
- Average price target
- $14.00
- High price target
- $28.00
- Low price target
- $8.00
- Low target gap
- +15.4%
- Target upside
- +102%
- High target gap
- +304%
- Target range width
- 288.6%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- September 12, 2026
- Valid through
- September 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for DarioHealth?
DarioHealth has a verified none consensus. The same dataset has an average price target of $14.00.
How far are DarioHealth's low and high targets from the recorded price?
The low target implies +15.4%, while the high target implies +304%.
How many analysts are included in DarioHealth's consensus?
The verified consensus includes 5 analysts.
How is DarioHealth's target upside or downside calculated?
The average target of $14.00 is divided by the recorded price of $6.93, then one is subtracted to produce +102%. This does not guarantee a future return.
When was DarioHealth's analyst forecast verified?
The data was verified on 2026-09-12. The dataset is valid through 2026-09-19.